Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA<sub>2</sub>β in pancreatic β-cells and in iPLA<sub>2</sub>β-null mice

American Journal of Physiology - Endocrinology and Metabolism - Tập 294 Số 2 - Trang E217-E229 - 2008
Shunzhong Bao1, David A. Jacobson2,3,4, Mary Wohltmann2,3,4, Alan Bohrer2,3,4, Wu Jin2,3,4, Louis H. Philipson2,3,4, John Turk2,3,4
1Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
21Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110
32Department of Medicine, University of Chicago, Chicago, Illinois 60637
4Washington University School of Medicine, Box 8127, 660 S. Euclid Ave., St. Louis, MO 63110;

Tóm tắt

Studies with genetically modified insulinoma cells suggest that group VIA phospholipase A2(iPLA2β) participates in amplifying glucose-induced insulin secretion. INS-1 insulinoma cells that overexpress iPLA2β, for example, exhibit amplified insulin-secretory responses to glucose and cAMP-elevating agents. To determine whether similar effects occur in whole animals, we prepared transgenic (TG) mice in which the rat insulin 1 promoter (RIP) drives iPLA2β overexpression, and two characterized TG mouse lines exhibit similar phenotypes. Their pancreatic islet iPLA2β expression is increased severalfold, as reflected by quantitative PCR of iPLA2β mRNA, immunoblotting of iPLA2β protein, and iPLA2β enzymatic activity. Immunofluorescence microscopic studies of pancreatic sections confirm iPLA2β overexpression in RIP-iPLA2β-TG islet β-cells without obviously perturbed islet morphology. Male RIP-iPLA2β-TG mice exhibit lower blood glucose and higher plasma insulin concentrations than wild-type (WT) mice when fasting and develop lower blood glucose levels in glucose tolerance tests, but WT and TG blood glucose levels do not differ in insulin tolerance tests. Islets from male RIP-iPLA2β-TG mice exhibit greater amplification of glucose-induced insulin secretion by a cAMP-elevating agent than WT islets. In contrast, islets from male iPLA2β-null mice exhibit blunted insulin secretion, and those mice have impaired glucose tolerance. Arachidonate incorporation into and the phospholipid composition of RIP-iPLA2β-TG islets are normal, but they exhibit reduced Kv2.1 delayed rectifier current and prolonged glucose-induced action potentials and elevations of cytosolic Ca2+concentration that suggest a molecular mechanism for the physiological role of iPLA2β to amplify insulin secretion.

Từ khóa


Tài liệu tham khảo

Arkhammar P, Nilsson T, Rorsman P, Berggren PO.Inhibition of ATP-regulated K+channels precedes depolarization-induced increase in cytoplasmic free Ca2+concentration in pancreatic beta cells.J Biol Chem262: 5448–5454, 1987.

10.1074/jbc.274.14.9400

10.1074/jbc.272.13.8576

10.1074/jbc.272.46.29317

10.1074/jbc.M509105200

10.2337/diabetes.53.2007.S186

10.1074/jbc.M701316200

10.1074/jbc.M406489200

10.1074/jbc.M600075200

10.1172/JCI200420016

10.1172/JCI13210

10.2337/diabetes.52.1.102

10.1016/j.cmet.2005.04.002

10.1038/311271a0

10.1136/bmj.328.7442.750

10.1056/NEJMoa052187

10.1097/00060793-199708000-00003

10.1152/ajpcell.1995.268.1.C181

10.1126/science.283.5404.981

10.2337/diacare.15.3.396

Ghosh A, Ronner P, Cheong E, Khalid P, Matschinsky FM.The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet β-cells in isolated perfused rat pancreas.J Biol Chem266: 22887–22892, 1991.

10.1083/jcb.145.6.1219

10.1074/jbc.274.29.20197

10.2337/diab.46.6.968

10.1016/S1044-0305(98)00012-9

10.1002/jms.491

10.1152/ajpendo.00110.2002

10.1016/j.cmet.2007.07.010

10.1074/jbc.M607858200

10.1074/jbc.M407841200

10.1016/0167-4889(92)90139-3

10.2337/diabetes.55.04.06.db05-1286

10.1074/jbc.M512373200

10.1074/jbc.272.17.11118

10.1074/jbc.M010423200

10.1016/S0079-6603(01)67023-5

10.1074/jbc.274.14.9607

10.1152/ajpendo.00165.2001

10.1007/s11892-005-0005-4

10.1002/dmr.5610020301

10.2337/diab.40.12.1565

10.1172/JCI8538

10.1016/j.ab.2005.04.042

10.1038/nbt1145

10.2337/diabetes.51.11.3141

Newgard CB, Hohmeier HE, Lu D, Jensen MC, Tran VV, Chen G, Gasa R, Burgess S, Sherry AD.Understanding basic mechanisms of β-cell function and survival: prelude to new diabetes therapies.Cell Biochem Biophys40: 159–168, 2004.

10.1074/jbc.M413711200

10.1074/jbc.274.4.2000

10.1074/jbc.M409706200

10.1152/physrev.1987.67.4.1185

10.1073/pnas.2536801100

10.1016/0165-0270(91)90017-T

10.1021/bi00052a042

10.1016/0006-291X(92)90638-2

10.1074/jbc.274.20.13915

10.1021/bi9722507

10.1016/S0005-2760(97)00189-6

10.1074/jbc.275.3.1587

10.1056/NEJMra032425

10.2337/diabetes.47.11.1713

10.1152/physrev.00001.2005

10.1056/NEJM200007273430401

10.2337/diabetes.47.9.1436

10.1016/S1388-1981(00)00105-0

10.1038/ncb1089

10.1210/me.2004-0169

10.1074/jbc.272.13.8567

10.1016/S0006-2952(96)00813-1

10.2337/diabetes.52.6.1423

10.2337/diab.42.3.367

10.1074/jbc.273.34.21926

10.1152/ajpendo.1989.257.2.E203

10.1074/jbc.M200330200

Wolf BA, Turk J, Sherman WR, McDaniel ML.Intracellular Ca2+mobilization by arachidonic acid. Comparison with myo-inositol 1,4,5-trisphosphate in isolated pancreatic islets.J Biol Chem261: 3501–3511, 1986.

10.1021/bi00240a004

10.1007/s001250050044

10.2337/diabetes.48.5.1006